Bioreducible shell-cross-linked hyaluronic acid nanoparticles for tumor-targeted drug delivery
The major issues of self-assembled nanoparticles as drug carriers for cancer therapy
include biostability and tumor-targetability because the premature drug release from and …
include biostability and tumor-targetability because the premature drug release from and …
Bioreducible shell-cross-linked hyaluronic acid nanoparticles for tumor-targeted drug delivery.
HS Han, T Thambi, KY Choi, S Son, H Ko… - …, 2015 - europepmc.org
The major issues of self-assembled nanoparticles as drug carriers for cancer therapy
include biostability and tumor-targetability because the premature drug release from and …
include biostability and tumor-targetability because the premature drug release from and …
Bioreducible shell-cross-linked hyaluronic acid nanoparticles for tumor-targeted drug delivery
HS Han, T Thambi, KY Choi, S Son… - …, 2015 - pubmed.ncbi.nlm.nih.gov
The major issues of self-assembled nanoparticles as drug carriers for cancer therapy
include biostability and tumor-targetability because the premature drug release from and …
include biostability and tumor-targetability because the premature drug release from and …
[PDF][PDF] Bioreducible Shell-Cross-Linked Hyaluronic Acid Nanoparticles for Tumor-Targeted Drug Delivery
HS Han, T Thambi, KY Choi, S Son, H Ko, MC Lee… - academia.edu
The major issues of self-assembled nanoparticles as drug carriers for cancer therapy
include biostability and tumor-targetability because the premature drug release from and …
include biostability and tumor-targetability because the premature drug release from and …
Bioreducible Shell-Cross-Linked Hyaluronic Acid Nanoparticles for Tumor-Targeted Drug Delivery
HS Han, T Thambi, KY Choi, S Son, H Ko, MC Lee… - Biomacromolecules, 2015 - Elsevier
The major issues of self-assembled nanoparticles as drug carriers for cancer therapy
include biostability and tumor-targetability because the premature drug release from and …
include biostability and tumor-targetability because the premature drug release from and …
Bioreducible Shell-Cross-Linked Hyaluronic Acid Nanoparticles for Tumor-Targeted Drug Delivery
HS Han, T Thambi, KY Choi, S Son… - …, 2015 - scholarworks.bwise.kr
The major issues of self-assembled nanoparticles as drug carriers for cancer therapy
include biostability and tumor-targetability because the premature drug release from and …
include biostability and tumor-targetability because the premature drug release from and …